Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients.

Pergam SA, Forsberg CW, Boeckh MJ, Maynard C, Limaye AP, Wald A, Smith NL, Young BA.

Transpl Infect Dis. 2011 Feb;13(1):15-23. doi: 10.1111/j.1399-3062.2010.00547.x.

2.

Incidence and risk factors for herpes zoster following heart transplantation.

Koo S, Gagne LS, Lee P, Pratibhu PP, James LM, Givertz MM, Marty FM.

Transpl Infect Dis. 2014 Feb;16(1):17-25. doi: 10.1111/tid.12149. Epub 2013 Oct 23.

3.

Incidence and risk factors of herpes zoster among adult renal transplant recipients receiving universal antiviral prophylaxis.

Pavlopoulou ID, Poulopoulou S, Melexopoulou C, Papazaharia I, Zavos G, Boletis IN.

BMC Infect Dis. 2015 Jul 24;15:285. doi: 10.1186/s12879-015-1038-1.

4.

Incidence of herpes zoster in patients with altered immune function.

Chen SY, Suaya JA, Li Q, Galindo CM, Misurski D, Burstin S, Levin MJ.

Infection. 2014 Apr;42(2):325-34. doi: 10.1007/s15010-013-0550-8. Epub 2013 Nov 10.

5.

Incidence and risk factors for herpes zoster in patients undergoing liver transplantation.

Hamaguchi Y, Mori A, Uemura T, Ogawa K, Fujimoto Y, Okajima H, Kaido T, Uemoto S.

Transpl Infect Dis. 2015 Oct;17(5):671-8. doi: 10.1111/tid.12425. Epub 2015 Sep 21.

PMID:
26201686
6.

Increased incidence of herpes zoster in the setting of cytomegalovirus preemptive therapy after kidney transplantation.

Ko GB, Kim T, Kim SH, Choi SH, Kim YS, Woo JH, Kim YH, Park JB, Lee SK, Park SK, Park JS, Han DJ, Lee SO.

Transpl Infect Dis. 2013 Aug;15(4):416-23. doi: 10.1111/tid.12091. Epub 2013 May 15.

PMID:
23676124
7.

Vaccination against zoster remains effective in older adults who later undergo chemotherapy.

Tseng HF, Tartof S, Harpaz R, Luo Y, Sy LS, Hetcher RC, Jacobsen SJ.

Clin Infect Dis. 2014 Oct;59(7):913-9. doi: 10.1093/cid/ciu498. Epub 2014 Aug 4.

PMID:
25097079
8.

End-stage kidney disease after pediatric nonrenal solid organ transplantation.

Ruebner RL, Reese PP, Denburg MR, Abt PL, Furth SL.

Pediatrics. 2013 Nov;132(5):e1319-26. doi: 10.1542/peds.2013-0904. Epub 2013 Oct 14.

9.

Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study.

Langan SM, Smeeth L, Margolis DJ, Thomas SL.

PLoS Med. 2013;10(4):e1001420. doi: 10.1371/journal.pmed.1001420. Epub 2013 Apr 9.

10.

Annual incidence rates of herpes zoster among an immunocompetent population in the United States.

Johnson BH, Palmer L, Gatwood J, Lenhart G, Kawai K, Acosta CJ.

BMC Infect Dis. 2015 Nov 6;15:502. doi: 10.1186/s12879-015-1262-8.

11.

Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era.

Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK.

Am J Transplant. 2004 Jan;4(1):108-15.

12.

Incidence and risk factors of herpes zoster among hiv-positive patients in the german competence network for HIV/AIDS (KompNet): a cohort study analysis.

Jansen K, Haastert B, Michalik C, Guignard A, Esser S, Dupke S, Plettenberg A, Skaletz-Rorowski A, Brockmeyer NH.

BMC Infect Dis. 2013 Aug 10;13:372. doi: 10.1186/1471-2334-13-372.

13.

Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic Drugs.

Pappas DA, Hooper MM, Kremer JM, Reed G, Shan Y, Wenkert D, Greenberg JD, Curtis JR.

Arthritis Care Res (Hoboken). 2015 Dec;67(12):1671-8. doi: 10.1002/acr.22628.

14.

Incidence and clinical characteristics of herpes zoster after lung transplantation.

Manuel O, Kumar D, Singer LG, Cobos I, Humar A.

J Heart Lung Transplant. 2008 Jan;27(1):11-6. doi: 10.1016/j.healun.2007.09.028.

PMID:
18187081
15.

Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-α inhibitors.

Segan J, Staples MP, March L, Lassere M, Chakravarty EF, Buchbinder R.

Intern Med J. 2015 Mar;45(3):310-8. doi: 10.1111/imj.12679.

PMID:
25565419
16.

The epidemiology of herpes zoster in patients with newly diagnosed cancer.

Habel LA, Ray GT, Silverberg MJ, Horberg MA, Yawn BP, Castillo AL, Quesenberry CP Jr, Li Y, Sadier P, Tran TN.

Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):82-90. doi: 10.1158/1055-9965.EPI-12-0815. Epub 2012 Nov 1.

17.

Short-term dipeptidyl peptidase-4 inhibitor use increases the risk of herpes zoster infection in Asian patients with diabetes.

Chen HH, Lin CL, Yeh SY, Kao CH.

QJM. 2016 Feb;109(2):91-5. doi: 10.1093/qjmed/hcv096. Epub 2015 May 18.

PMID:
25991869
18.

Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.

Tseng HF, Smith N, Sy LS, Jacobsen SJ.

Vaccine. 2011 May 9;29(20):3628-32. doi: 10.1016/j.vaccine.2011.03.018. Epub 2011 Mar 22.

PMID:
21435407
19.

Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort.

Torre-Cisneros J, Doblas A, Aguado JM, San Juan R, Blanes M, Montejo M, Cervera C, Len O, Carratala J, Cisneros JM, Bou G, Muñoz P, Ramos A, Gurgui M, Borrell N, Fortún J, Moreno A, Gavalda J; Spanish Network for Research in Infectious Diseases.

Clin Infect Dis. 2009 Jun 15;48(12):1657-65. doi: 10.1086/599035.

PMID:
19445585
20.

Hodgkin lymphoma among US solid organ transplant recipients.

Quinlan SC, Landgren O, Morton LM, Engels EA.

Transplantation. 2010 Nov 15;90(9):1011-5. doi: 10.1097/TP.0b013e3181f5c3a6.

Supplemental Content

Support Center